Psychotherapy and antidepressants treat only about one-third of patients who suffer depression, but a magnetic therapy is promising, a U.S. researcher said. Dr. Murali Rao of Loyola University Medical Center in Maywood, Ill., said nearly 300 U.S. centers offer the treatment, called transcranial magnetic stimulation, a treatment that sends short pulses of magnetic fields to the brain. At Loyola, about two-thirds of Rao's transcranial magnetic stimulation patients reported their depression has significantly lessened or gone away completely. In 2009, the U.S. Food and Drug Administration approved transcranial magnetic stimulation for patients who have major depression and have failed to experience improvement from at least one antidepressant. One transcranial magnetic stimulation system, NeuroStar, made by Neuronetics, has the patient recline in a comfortable padded chair. A magnetic coil is placed next to the left side of the head that sends short pulses of magnetic fields to the surface of the brain, producing currents that stimulate brain cells, Rao said. The currents, in turn, affect mood-regulatory circuits deeper in the brain. The resulting changes in the brain appear to be beneficial to patients who suffer depression, Rao said. Each treatment lasts 35 to 40 minutes. Patients typically undergo three treatments per week for four-to-six weeks, Rao explained. The treatments do not require anesthesia or sedation, and a patient can immediately resume normal activities, including driving.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor